biote Corp.
BTMD | NASDAQ
$1.11
-$0.06 (-5.13%)
At close: Oct 30, 2026, 4:00 PM ET
$1.11
$0.00 (0.00%)
After-hours:
Oct 30, 2026, 7:30 PM ET
-5.13%
(1D)No price chart data available for 1D timeframe.
Rating
42.2
Fundamentals Average
Market Sentiment Neutral
Moat Narrow
Sector Rank #474/1028 (Top 46%)
Key Statistics
Market Data
Market Cap $48.96M
1D Range
1.11 1.22
52W Range
1.03 2.93
Valuation (TTM)
PE 9.25
PB -0.74
EV/EBITDA 7.09
Valuation (NTM)
Forward PE 5.93
Forward PEG -0.07
Price Target $4.91
Cash Flow
FCF Yield 40.2%
SBC Adj. FCF Yield 23.2%
SBC Impact -42.4%
Margins
Gross Margin 60.2%
Operating Margin 8.0%
FCF Margin 10.7%
Growth (CAGR)
Revenue 3Y | 5Y 0.6% |
13.6%
Dil EPS 3Y | 5Y 1.3% |
-49.6%
FCF 3Y | 5Y -13.4% |
-3.4%
Returns
ROA 5.8%
ROE -9.3%
ROIC 13.5%
Financial Health
Net Debt
$110.33M
Current Ratio 1.43
Interest Coverage 1.58
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Biote Corp. is dedicated to supporting and developing medical practices that focus on hormone optimization. The company provides a comprehensive system for its Biote-certified healthcare professionals...
Sector Healthcare
Industry Medical - Care Facilities
Employees 223
IPO Date Apr 28, 2021
Website biote.com
Fiscal Year January - December
Latest News
No news articles available yet.
Analyst Summary
# of Analysts
3
Consensus
Buy
Price Target
$4.00
Upside
+260.36%
Buy (2)
Hold (1)
Sell (0)
Add to Watchlist
Select watchlists to add or remove BTMD